Thrombopenia and/or Splenomegaly in HIV/HCV Co-Infected Patients With Mild Liver Fibrosis Alerts for the Risk of Portal Hepatopathy

Journal of the International AIDS Society - Switzerland
doi 10.1186/1758-2652-11-s1-p286
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Correction of Metabolic Disorders in Patients Co-Infected With HIV/HCV

ScienceRise
2015English

Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients

Antiviral Therapy
Infectious DiseasesPharmacology
2014English

Liver Disease Progression in HIV/HCV Co-Infected Patients: A Role for Metalloproteinases and Their Specific Inhibitors

Retrovirology
VirologyInfectious Diseases
2006English

Changes of Body Immunity and Inflammatory Response in HIV/HCV Co-Infected Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Current Possibilities to Assess the Degree of Liver Fibrosis in Patients With Haemophilia Infected With HCV - Review

Advances in Clinical and Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Survival of HIV/HCV Co-Infected Patients Before Introduction of HCV Direct Acting Antivirals (DAA)

Scientific Reports
Multidisciplinary
2019English

Association of Non-Invasive Markers of Liver Fibrosis With HCV Coinfection and Antiretroviral Therapy in Patients With HIV

Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
Multidisciplinary
2019English

PHS60 Health-Related Quality of Life in HIV/HCV Co-Infected Patients in Ireland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV Co-Infected Patients: Implications for Treatment Outcomes

Journal of Hepatology
Hepatology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy